非对映消旋体2-氨基-3-氰基-1-苯基-4-(3,4-亚甲二氧苯基)-2-环戊烯-1-醇的合成和晶体结构

用低价钛试剂(Ticl₄-Zn)与3-氧代-1-(3',4'-亚甲二氧苯基)-3-苯基丙基-1-丙二腈反应合成了非对映消旋体(1S,4R;1R,4S)和(1S,4S;1R,4R)2-氨基-3-氰基-1-苯基-4-(3,4-亚甲二氧苯基)-2-环戊烯-1-醇,用X射线衍射分析确定了这两个异构体的相对构型.     

新型3-五元碳环螺环氧化吲哚类化合物的合成及其抗人白血病细胞活性

以氧化吲哚与邻芳基二甲醛为原料,经Knoevenagel缩合(或Michael,环化反应),制得7个3-五元碳环螺环氧化吲哚(4a~4c,产率67%~86%,d/r值4∶1~10∶1)和4d~4g;4d~4g与哌啶(或四氢吡咯)和多聚甲醛经胺甲基化反应,合成了4个3-五元碳环螺环氧化吲哚(5d~5g),产率55%~67%,d/r值10∶1~20∶1,其结构经~1H NMR,~(13)C NMR和HR-MS(ESI-TOF)表征。采用MTT法研究了4a~4c和5d~5g对人白血病细胞(K562)的体外抗肿瘤活性。结果表明:4b,5d和5f对K562抑制活性较好,IC50分别为29.3μmol·L~(-1),27.4μmol·L~(-1)和34.2μmol·L~(-1),与阳性对照药顺铂(26.8μmol·L~(-1))相当。     

Design of Novel Binuclear Phthalocyanines formed by Dioxyphenyl Bridges: Synthesis and Investigation of Thermal and Antioxidant Properties

4, 4′‐(1, 4‐Phenylenebis(oxy)diphthalonitrile was synthesized by reaction of hydroquinone with 4‐nitrophthalonitrile. Binuclear metallophthalocyanines 2–4 were obtained by the reaction between 4, 4′‐(1, 4‐phenylenebis(oxy)diphthalonitrile and 4‐(benzo [d] 1 , 3 dioxol‐5‐ylmethoxy)phthalonitrile in the presence of metal salts. These new compounds were characterized by using elemental analysis, FTIR, ¹H‐NMR and UV/Vis spectroscopic data. Thermal properties of phthalocyanines 2‐4 were investigated by TG and DTA. In addition, antioxidant properties of compounds II , 3 and 4 were investigated. Their radical‐scavenging capacity and chelating effects was fully studied. The maximum 1, 1‐diphenyl‐2‐picrylhydrazyl radicals (DPPH) were obtained from compound 3 . Chelating effects on ferrous ions were 91.6 % at concentration of 100 mg L^–1 with compound II .     

X-ray crystal structures, electron paramagnetic resonance, and magnetic studies on strongly antiferromagnetically coupled mixed mu-hydroxide-mu-N(1),N(2)-triazole-bridged one dimensional linear chain copper(II) complexes

Four new metal-organic polymeric complexes, {[Cu(mu-OH)(mu-ClPhtrz)][(H 2O)(BF 4)]} n ( 1), {[Cu(mu-OH)(mu-BrPhtrz)][(H 2O)(BF 4)]} n ( 2), {[Cu(mu-OH)(mu-ClPhtrz)(H 2O)](NO 3)} n ( 3), and {[Cu(mu-OH)(mu-BrPhtrz)(H 2O)](NO 3)} n ( 4) (ClPhtrz = N-[( E)-(4-chlorophenyl)methylidene]-4 H-1,2,4-triazol-4-amine; BrPhtrz = N-[( E)-(4-bromophenyl)methylidene]-4 H-1,2,4-triazol-4-amine), were synthesized in a reaction of substituted 1,2,4-triazole and various copper(II) salts in water/acetonitrile solutions. The structures of 1- 4 were characterized by single-crystal X-ray diffraction analysis. The Cu(II) ions are linked both by single N (1), N (2)-1,2,4-triazole and hydroxide bridges yielding one dimensional (1D) linear chain polymers. The tetragonally distorted octahedral geometry of copper atoms is completed alternately by two water and two BF 4 (-) anion molecules in 1 and 2 but solely by two water molecules in 3 and 4. Magnetic properties of all complexes were studied by variable temperature magnetic susceptibility measurements. The Cu(II) ions are strongly antiferromagnetically coupled with J = -419(1) cm (-1) ( 1), -412(2) cm (-1) ( 2), -391(3) cm (-1) ( 3), and -608(2) cm (-1) ( 4) (based on the Hamiltonian H = - J[ summation operator S i . S i+ 1]). The nature and the magnitude of the antiferromagnetic exchange were discussed on the basis of complementarity/countercomplementarity of the two competing bridges.     

N-[2-(4-吗啉基)乙基]苯甲酰胺类单胺氧化酶抑制剂的合成及其生物活性研究

以取代苯甲酸为原料,经缩合反应制得N-(2-溴乙基)苯甲酰胺类化合物(4a~4i);4a~4i经N-烷基化反应合成N-[2-(4-吗啉基)乙基]苯甲酰胺类化合物(1a~1i),其结构经~1H NMR,~(13)C NMR,MS和元素分析表征。并对其生物活性进行了初步实验。实验结果表明:1a~1i对单胺氧化酶(MAO-A)有良好的抑制作用,其中1a最好,当IC50=3.652μmol·L~(-1)时,SI=42.32。     

新型吲唑类化合物的合成及其抗肿瘤活性

以2,6-二氟苯腈与吗啉反应制得2-氟-6-吗啉-苯腈(1); 1与水合肼在N-甲基吡咯烷酮中通过环合反应制得3-氨基-4-吗啉-1H-吲唑(2); 2与不同羧酸经缩合反应合成了8个新型吲唑类化合物(4a~4h),其结构经¹H NMR, IR和HR-ESI-MS表征。抗肿瘤活性测试结果表明：3,4,5-三甲氧基-氮-(4-吗啉-1H-吲唑-3-基)苯甲酰胺（4a）的抗肿瘤活性最好,对K-562, SMMC7721和T-47D肿瘤细胞有明显抑制作用,IC₅₀分别为0.056 μmol·L^-1, 0.062 μmol·L^-1和0.078 μmol·L^-1。     

(硫杂)杯[4]芳烃缩氨基(硫)脲(桥联)衍生物的合成

对叔丁基(硫杂)杯[4]芳烃-1,3-二醛基衍生物4a和4b与苯基氨基硫脲进行“1＋2”缩合反应, 合成了杯[4]芳烃缩氨基硫脲衍生物5a和5b, 产率为84%和85%. 化合物4a和4b与1,6-己基双氨基脲发生“1＋1”缩合反应, 合成了杯[4]芳烃双缩氨基脲桥联衍生物6a和6b, 产率为83%和80%. 新化合物的结构与构象经元素分析、质谱、核磁共振谱等表征证实.     

含咪唑功能基的手性羧酸酯和脂肪醇的合成

含咪唑功能基的手性羧酸酯和脂肪醇的合成;天然氨基酸;手性咪唑羧酸酯;手性咪唑脂肪醇;合成     

新型1-(4-取代苯基)-3-[4-(4-氧香豆素基)苯基]硫脲衍生物的合成及其抑菌活性

以4-羟基香豆素为原料,经氯化、醚化和异硫氰酸化3步反应制得中间体——4-(4-异硫氰酸酯苯氧基)香豆素(3);3与取代芳香胺经加成反应合成了9个新型的1-(4-取代苯基)-3-[4-(4-氧香豆素基)苯基]硫脲衍生物(4a~4i),其结构经1H NMR,13C NMR,IR和MS(ESI)表征。采用浑浊度法测试了4的抑菌活性。结果表明:4a、4b、4e和4f抑制烟草青枯菌活性EC50值分别为112.02、121.39、88.72和86.90μg·mL~(-1),优于噻菌铜(130.25μg·mL~(-1));4a、4b、4e和4f抑制番茄青枯菌活性EC50值分别为107.89、110.69、82.43和82.48μg·mL~(-1),优于噻菌铜(123.94μg·mL~(-1))。     

Synthesis and Bioactivity of Novel Aminomethyl-2-（1, 2,4-triazol）-4, 4-dimethyl-3-pentanone （ol）

3, 3-Dimethyl-1-(1,2,4-triazol)-2-butanone was treated with aqueous formaldehyde to give an additional product, and subsequent elimination by acetic anhydride yielded 4,4-dimethyl-2-(1,2,4-triazol)-1-penten-3-one. Further addition with substituted amines provideda series of (1,2,4-triazol)-4,4-dimethyl-3-pentanone, which were then reduced by KBH4 to obtaina series of (1,2,4-triazol)-4,4-dimethyl-3-pentanol. Their structures were confirmed by ^1HNMR and elemental analysis. The results of bioassay showed that the title products possess good fungicidal activities.     

4-氧代-3（4H）-喹唑啉-5-羧酸的合成

以2-氨基-6-甲基苯甲酸为起始原料,通过合环反应生成两种4-氧代-3(4H)-喹唑啉-5-羧酸衍生物(1a, 1b), 1a, 1b分别经高锰酸钾氧化合成了4-氧代-3(4H)-喹唑啉-5-羧酸（2a, 2b）,其结构经¹H NMR, ¹³C NMR和MS表征。研究了投料比｛r［n(高锰酸钾) :n(5-甲基-3(4H)-喹唑啉-4-酮)］｝和反应温度等对收率的影响。结果表明：在最佳反应条件（r=7:1,中性高锰酸钾氧化,于90 ℃反应）下合成2总收率可达66%。     

Synthesis and Characterization of new Monomers and Polymers Containing Hindered Piperidine Groups

Abstract

Two new methacryloyl ureas, 1-(2-methylacryloyl)-3-(2,2,6,6-tetra-methylpiperidin-4-yl)-urea and 1-butyl-3-(2-methylacryloyl)-1-(2,2,6,6-tetramethylpiperidin-4-yl)-urea (monomer I and monomer II), were prepared by the addition reaction of 2-methylacryloyl iso-cyanate with 2,2,6,6-tetramethylpiperidin-4-yl-amine or butyl-(2,2,6,6-tetramethylpiperidin-4-yl)-amine in a molar ratio of 1:1 at low or room temperature. In a similar way, the syntheses of two new methacryloyl carbamates, 1-(2,2,6,6-tetra-methylpiperidin-4-yl)-3-(2-methylacryloyl)-carbamate and l-(1,2,2,6,6-pentamethyl-piperidin-4-yl)-3-(2-methylacryloyl)-carbamate (monomer III and monomer IV), were completed by the reaction of 2,2,6,6-tetra-methylpiperidin-4-ol or 1,2,2,6,6-pentamethylpiperidin-4-ol with 2-methylacryloyl isocyanate in the presence of dibutyltin dilaurate as catalyst at 60°C. The four new monomers were homopolymerized, and copolymerized with styrene by AIBN as initiator at 70°C. The structures of the new monomers and their polymers were characterized by FT-IR and NMR spectroscopy and by GPC.     

Gelation and its relevance to the function of polysaccharides

(1→4)-α- and (1→4)-β-D-linked glucosidic oligosaccharide chains were generated by the Monte Carlo method, and the scattering from the systems composed of simulated chains was calculated to compare with the results of small-angle X-ray scattering from the oligosaccharides in aqueous solution. By extending the simulation to a longer chain, a single chain conformation of (1→4)-α- and (1→4)-β-D-linked polysaccharides was evaluated. On the basis of the simulation, the suprastructure of (1→4)-α- and (1→4)-β-D-linked polysaccharides and their gel formation mechanism were discussed in some detail by analyzing the small-angle X-ray scattering from the aqueous solutions of (1→4)-α- and (1→4)-β-D-linked polysaccharides.     

Notizen zur Synthese sulfonierter Derivate von 5,6,7,8-Tetrahydro-1-naphthylamin und 5,6,7,8-Tetrahydro-2-naphthylamin

Notes on the Synthesis of Sulfonated Derivatives of 5,6,7,8-Tetrahydro-1-naphthylamine and 5,6,7,8-Tetrahydro-2-naphthylamine Sulfonation of 5,6,7,8-tetrahydro-1-naphthylamine ( 1 ) with sulfuric acid gave a mixture of 1-amino-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 2 ), 4-amino-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 13 ) and 4-amino-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 3 ). The same reaction with 5,6,7,8-tetrahydro-2-naphthylamine ( 20 ) yielded 3-amino-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 21 ); formation of 2-amino-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 16 ) or of 3-amino-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 24 ) was not observed. Treatment of 4-bromo-5,6,7,8-tetrahydro-1-naphthylamine ( 4 ) or of its 4-chloro analogue 5 with amidosulfuric acid gave 1-amino-4-bromo-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 9 ) and its 4-chloro analogue 10 , respectively, which were dehalogenated to 2 . Preparations of 13 and 24 were achieved by sulfonation of 5-nitro-1,2,3,4-tetrahydronaphthalene ( 14 ) and 6-nitro-1,2,3,4-tetrahydronaphthalene ( 22 ) to 4-nitro-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 15 ) and 3-nitro-5,6,7,8-tetrahydronaphthalene-1-sulfonic acid ( 23 ), respectively, followed by Béchamp reductions. The sulfonic acid 13 was also obtained by hydrogenolysis of 4-amino-1-bromo-5,6,7,8-tetrahydronaphthalene-2-sulfonic acid ( 11 ) or of its 1-chloro analogue 12 ; compounds 11 and 12 were synthesized from N-(4-bromo-5,6,7,8-tetrahydro-1-naphthyl)acetamide ( 7 ) and from its 4-chloro analogue 8 , respectively, by sulfonation with oleum and subsequent hydrolysis. By ‘baking’ the hydrogensulfate salt of 1 or 20 compounds 3 and 21 were obtained, respectively. Synthesis of 16 was achieved by sulfur dioxide treatment of the diazonium chloride derived from 2-nitro-5,6,7,8-tetrahydro-1-naphthylamine ( 17 ) giving 2-nitro-5,6,7,8-tetrahydronaphthalene-1-sulfonyl chloride ( 18 ), followed by hydrolysis of 18 to the corresponding sulfonic acid 19 and final reduction.     

新型苯并咪唑类配体配合物的合成及其性能

以苯并咪唑（HL¹）和3,6 二氯哒嗪在钠催化下反应制得配体3-氯-6-(苯并咪唑-1-基)哒嗪(L²）;采用溶液法和水热法,L¹分别与含有银、铜过渡金属盐反应合成了3种新的有机金属苯并咪唑配合物［AgL¹］_n(1),［Cu₄(HL¹)₄(O)(Cl)₆］(2)和{［Cu(HL¹)₂］·SiF₆}(3);采用溶液法,L²与Zn(NO₃)₂·6H₂O经配位反应合成了配合物{［Zn(L²)₃(NO₃)］NO₃}(4),其结构经IR,元素分析和X-射线单晶衍射表征。结果表明：1通过苯并咪唑桥连形成一维链状结构,2由苯并咪唑和氯离子桥接形成四核结构,3和4均显示一个单核结构,3的金属中心原子采用二配位构型,4的金属中心原子采用四配位构型。此外,研究了配体HL¹与1,及配体L²与4的荧光性能。结果表明：与HL¹相比,1的最大发射波长发生了红移;而4相对于配体L²其最大发射峰发生明显蓝移。     

Plant growth inhibitory activity of azo- and azoxyformamides from Calvatia craniiformis and Lycoperdon hiemale

4-Methoxybenzene-1-ONN-azoxyformamide (1), 4-methoxybenzene-1-azoformamide (2), 4-hydroxyben-zene-1-azoformamide (3) and 4-hydroxybenzene-1-ONN-azoxyformamide (4) were isolated from the fruiting bodies of Calvatia craniiformis and Lycoperdon hiemale, respectively. Compounds 1 and 4 showed radicle growth inhibitory activities against the lettuce seedlings by more than 50% at 5.0 x 10(-1) mM, suggesting that the azoxy moiety contributes to the inhibitory activity. The plant growth inhibitory activities of 1, 2 and 4 against the barnyard millet seedlings were also measured.     

Syntheses of 2-chloro-4-nitrophenyl beta-D-maltopentaosides with bulky modification and their application to the differential assay of human alpha-amylases.

Four novel maltopentaosides, 2-chloro-4-nitrophenyl O-(6-O-p-toluenesulfonyl-alpha-D-glucopyranosyl)-(1-->4)-tris[O- alpha-D-glucopyranosyl-(1-->4)]-beta-D-glucopyranoside (4), 2-chloro-4-nitrophenyl O-[6-O-(tert-butyldimethyl)silyl-alpha-D- glucopyranosyl]-(1-->4)-tris[O-alpha-D-glucopyranosyl-(1-->4)]-beta-D- glucopyranoside (5), 2-chloro-4-nitrophenyl O-[6-deoxy-6-(phenyl)sulfonyl-alpha-D- glucopyranosyl]-(1-->4)-tris[O-alpha-D-glucopyranosyl-(1-->4)]-beta-D- glucopyranoside (10), and 2-chloro-4-nitrophenyl O-(6-deoxy-6-phthalimido-alpha-D-glucopyranosyl)- (1-->4)-tris[O-alpha-D-glucopyranosyl-(1-->4)]-beta-D-glucopyranoside (11) were synthesized. Substrates 4, 5, 10, and 11 were hydrolyzed by human pancreatic alpha-amylase (HPA) from 1.1 to 2.9-fold faster than by human salivary alpha-amylase (HSA). Taking advantage of the difference in the hydrolytic rate of 5 (2.9-fold faster), we developed a new method for the differential assay of these two human alpha-amylases.     

新型吲唑类PARP-1抑制剂的合成及其生物活性评价

以3-甲基-2-硝基苯甲酸甲酯为起始原料,经两步反应制得中间体1H-吲唑-7-甲酸甲酯(3); 3分别与三氯氧磷、液溴和碘单质反应制得3的3-位卤代产物(4b~4d); 4d与氟试剂或氰化锌反应制得3-氟(氰基)-3(4a和4e); 4d与苯硼酸或甲基硼酸在四三苯基磷钯催化下反应制得3-甲基(苯基)-3(5a和5b);以氢化钠为碱,3, 4a~4c, 4e, 5分别与4-甲烷磺酰氧基哌啶或3-甲烷磺酰氧基四氢吡咯经缩合反应制得3的2,3-位取代产物(6a～6n); 6a～6n在甲醇中氨解,随后采用氯化氢气体脱去Boc保护基合成了14个新型吲唑类PARP-1抑制剂(7a～7n),其结构经¹H NMR和ESI-MS表征。生物活性评价结果显示,有7个目标化合物对PARP-1酶活性抑制IC₅₀低于30 nmol·L^-1,其中2-(四氢吡咯-4-基)-2H-吲唑-7-甲酰胺(7e)和3-氟-2-(四氢吡咯-4-基)-2H-吲唑-7-甲酰胺(7f)的IC₅₀分别为4.2 nmol·L^-1和4.6 nmol·L^-1。     

带有四个不同芳基的环丁烷的合成、结构及光化学性质

通过不同杂芳基乙烯分子间的交叉光二聚反应在硫酸溶液中和中压汞灯照射下,合成了4种含7个不同取代芳基的环丁烷衍生物.用紫外和红外光谱及¹H和¹³CNMR谱确定其结构为顺式头尾相对型二聚体.     

Synthesis of novel 6-(substituted amino)-4-(4-ethoxyphenyl)-1-phenyl-2(1H)-pyridinones via azo coupling

Abstract  

6-(Substituted amino)-4-(4-ethoxyphenyl)-1-phenyl-2(1H)-pyridinones were prepared from β-aryl glutaconic acid, which, on fusion with aniline, results in 4-(4-ethoxyphenyl)-1-phenylpyridine-2,6(1H,5H)-dione. This, on further treatment with phosphorus oxychloride gave 6-chloro-4-(4-ethoxyphenyl)-1-phenyl-2(1H)-pyridinone, and further treatment with secondary amines yielded 6-(substituted amino)-4-(4-ethoxyphenyl)-1-phenyl-2(1H)-pyridinones. These were subjected to azo coupling with different aryldiazonium chlorides furnishing two isomers, which were separated by column chromatography. All compounds were characterized by elemental analysis, and use of IR and NMR spectral data, and were evaluated for antimicrobial activity.